期刊文献+

6213株细菌院内分布及耐药分析 被引量:1

下载PDF
导出
摘要 随着各种抗菌药物的广泛使用,耐药细菌也日渐增多,因此做好细菌耐药监测工作为临床提供参考尤为重要。本研究收集本院临床分离的细菌,分析其菌群分布、耐药性。1材料与方法1.1细菌来源选择我院2015年1月—9月临床分离的细菌,剔除同一患者相同部位的重复菌株,不收集厌氧菌和真菌。标本来源有痰、尿液、分泌物、血液、胆汁。1.2方法细菌鉴定和药敏试验采用VITEK compact系统。
出处 《浙江中西医结合杂志》 2016年第5期473-475,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献7

  • 1郭宇,王辉,赵春江,张菲菲,王占伟,曹彬,徐英春,陈民钧,胡必杰,倪语星,张莉滟,廖康,杨青,俞云松,徐修礼,褚云卓,胡志东,孙自镛,梅亚宁,刘智勇.2013年中国革兰阳性球菌多中心耐药监测研究[J].中华检验医学杂志,2015,38(6):373-381. 被引量:23
  • 2Ho PL,Lo PY,Chow KH,et al.Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong [ J ] .J Infect, 2020,60 ( 2 ) : 140-145.
  • 3Musta AC,Riederer K,Shemes S,et al.Vancomyein MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureusbacteremia : trends over 11 years [ J ].J Clin Microbiol, 2009,47 (6) : 1640-1644.
  • 4郭宇,王辉,赵春江,王占伟,曹彬,徐英春,胡必杰,倪语星,张莉滟,廖康,杨青,俞云松,雷金娥,徐修礼,褚云卓,胡志东,孙自镛,梅亚宁,刘智勇.2012年中国16家医院革兰阳性球菌耐药监测研究[J].中华微生物学和免疫学杂志,2013,33(6):401-409. 被引量:22
  • 5Tumbarello M, spanu T, sanguinetti M, et al.Bloodstream in- fections caused by extended-spectmm-13-1actamase-pro- ducing Klebsiella pneumoniae:risk factors, molecular epi- demiology and clinical outcome[J].Antimicrob Agents Che- mother, 2006,50(2 ) : 498-504.
  • 6杨彬,张坚磊,郭影,穆红,彭林.2011年第四季度天津市细菌耐药性监测[J].中华医院感染学杂志,2012,22(16):3639-3642. 被引量:2
  • 7Cai JC,Zhon HW,Zhang R,et al.Emergence of serratia mareescens,klebsiella pneumoniae and escheriehia eoli possessing the plasmid-mediated earbapenem-hydmlizing beta-lactamase KPC-2 in intensive care units from a Chi- nese hospital [J ].Antimicrob Agents Chemother, 2008,52 (6) :2014-2018.

二级参考文献31

  • 1王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 2Clinical and Laboratory Standards Institute.Performance Stand-ards for Antimicrobial Susceptibility Testing[S].M100-S18.CLSI,2008.
  • 3Bush K.Alarmingβ-lactamase-mediated resistance in multi-drug-resistant enterobacteriaceae[J].Curr Opinion Microb,2010,13:558-564.
  • 4Rice LB. Antimicrobial resistance in gram-positive bacteria [ J]. Am J Infect Control, 2006, 34(5 Suppl 1 ) : S11-$19, $64-$73.
  • 5Shibl AM, Memish ZA, Kambal AM, et al. National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia [J]. J Chemother, 2014, 26(1) : 13-18.
  • 6CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational. Supplement. CLSI document M100-$24. Wayne, PA: Clinical and Laboratory Standards Institute, 2014.
  • 7Freire AT, Melnyk V, Kim MJ, et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia[J]. Diagn Microbiol Infect Dis, 2010, 68(2): 140- 151.
  • 8Zhao C, Sun H, Wang H, et al. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005- 2010) [J]. Diagn Microbiol Infect Dis, 2012, 73(2) : 174-181.
  • 9Yao KH, Wang LB, Zhao GM, et al. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia [J]. Vaccine, 2011,29(12): 2296- 2301.
  • 10Kim SH, Song JH, Chung DR, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study [ J ]. Antimicrob Agents Chemother, 2012, 56(3) : 1418-1426.

共引文献38

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部